Expressive

rs116539780 - LINC01493 - RNU6-99P

Magnitude 2.2 · 1 study on file

Reported associations

  • Genome-wide meta-analysis of insomnia prioritizes genes associated with metabolic and psychiatric pathways. - Nature genetics (2022) · Watanabe K, Jansen PR, Savage JE, Nandakumar P, Wang X, Hinds DA, Gelernter J, Levey DF, Polimanti R, Stein MB, Van Someren EJW, Smit AB, Posthuma D · PubMed 35835914

    Insomnia is a heritable, highly prevalent sleep disorder for which no sufficient treatment currently exists. Previous genome-wide association studies with up to 1.3 million subjects identified over 200 associated loci. This extreme polygenicity suggested that many more loci remain to be discovered. The current study almost doubled the sample size to 593,724 cases and 1,771,286 controls, thereby increasing statistical power, and identified 554 risk loci (including 364 novel loci). To capitalize on this large number of loci, we propose a novel strategy to prioritize genes using external biological resources and functional interactions between genes across risk loci. Of all 3,898 genes naively implicated from the risk loci, we prioritize 289 and find brain-tissue expression spec

Auto-generated from study metadata. AI-synthesised commentary is added when this entry is regenerated through content-service's LLM mode.

Lifestyle context

Concrete actions anchored to the cited research. We do not prescribe, we describe.

Discuss with your doctor

  • genetic insomnia risk and preventive strategies Moderate

    rs116539780 T allele is associated with insomnia susceptibility in GWAS of 2.3 million individuals

    discuss with healthcare provider if experiencing sleep issues; may warrant earlier screening or targeted interventions

Lifestyle

  • sleep hygiene optimization Moderate

    rs116539780 T allele associates with increased insomnia risk; targeted sleep practices may mitigate genetic predisposition

    establish consistent sleep schedule, aim for 7-9 hours nightly, maintain cool dark bedroom, limit caffeine after 2pm

Screening

  • sleep quality and insomnia symptoms Moderate

    rs116539780 T allele carriers have elevated genetic risk for insomnia per large-scale GWAS

    track sleep duration and daytime symptoms weekly; alert clinician if persistent sleep disruption occurs